학술논문
Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study
Document Type
Article
Author
Source
In: The Lancet Oncology . (The Lancet Oncology, August 2022, 23(8):1066-1077)
Subject
Language
English
ISSN
14745488
14702045
14702045